🦊/Companies

CB Therapeutics

YC S18

San Diego, US · Founded 2015 · Incorporated in Cayman Islands · 18 employees · 4 known investors

Find your way into CB Therapeutics

702 people in our graph share verified history with the CB Therapeutics team — schools, employers, funds. One of them is your warm intro.

David Phuunlockedknows Jacob Vogan · together at University of California, Davis (overlapped)
×2knows the team · via University of California, Davis
×6knows the team · via Y Combinator
knows the team · via University of California, San Francisco
knows the team · via UC San Diego
knows the team · via East China Normal University

CB Therapeutics builds a yeast platform for biosynthesis of molecules including psychedelics, cannabis, and alkaloids that are difficult to source through conventional methods. The company serves pharmaceutical and specialty chemical manufacturers.

AI & Machine LearningBiotechDeep TechHealthtechCellular AgricultureUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (S18)

CB Therapeutics was founded in 2015 by Sher Butt, Jacob Vogan, and Jason (Zhen) Qi.

SBSher Butt
Sher ButtinCoFounder, CEO, & Board Member
JVJacob Vogan
Jacob VoganinCo-Founder and Chief Scientific Officer (CSO)Jacob Vogan co-founded CB Therapeutics, a company developing biological supply chains for rare natural products intended for therapeutic use.
J(
Jason (Zhen) QiinCo-FounderJason Zhen Qi holds an MBA from UC San Diego's Rady School of Management and previously worked as a senior manager in corporate banking at SPD Bank from 2008 to 2013, followed by roles in venture capital and corporate banking consulting.
GY
Guoliang YuExecutive

Board

BZ
Bing ZhuResignation effective upon this financing.
AW
Alex WuResignation effective upon this financing.
JW
Jonathan WangAppointment effective upon this financing.
SR
Sanjeev RedkarAppointment effective upon this financing.

Investors · 4

Funding

SEC filings, press & company announcements

$4M disclosed across 1 of 2 rounds · 2016–2021

  • Undisclosed amountSeries AMay 2021 · 2 sources
    Source ↗
$4MraisedAug 2016 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Bing ZhuExecutive Officer
  • Sanjeev RedkarExecutive Officer, Director
  • Alex WuDirector
  • Jonathan WangDirector
  • Guoliang YuExecutive Officer, Director
Offering amount
$7.8M
Amount sold
$4M
First sale
Jul 2016
Incorporated
Other, Cayman Islands, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with CB Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does CB Therapeutics do?
CB Therapeutics builds a yeast platform for biosynthesis of molecules including psychedelics, cannabis, and alkaloids that are difficult to source through conventional methods. The company serves pharmaceutical and specialty chemical manufacturers.
Who founded CB Therapeutics?
CB Therapeutics was founded by Sher Butt, Jacob Vogan, Jason (Zhen) Qi in 2015.
Who are CB Therapeutics's investors?
CB Therapeutics's investors include aVenture, James Beshara Fund, Metaplanet, Y Combinator.
How much funding has CB Therapeutics raised?
CB Therapeutics has disclosed $4M raised across 1 of its 2 known rounds.
Where is CB Therapeutics headquartered?
CB Therapeutics is headquartered in San Diego, US.